Skip to main content
. 2013 Dec 5;5(3):297–304. doi: 10.1111/jdi.12178

Table 5. Odds ratio of colorectal adenoma according to quartiles of fasting serum insulin stratified by fasting blood glucose.

OR (95% CI) P for trends
FBS < 100 mg/dL Q1 Q2 Q3 Q4
Insulin, μIU/mL (median) <3.3 (2.29) 3.3–4.7 (4.03) 4.7–6.6 (5.62) >6.6 (9.57)
Adenoma cases/non–cases 516/1,130 529/1,025 520/954 557/985
Univariate 1.0 (ref) 1.13 (0.98 –1.31) 1.19 (1.03 –1.39)a 1.24 (1.07 –1.44)a <0.05
Model 1 1.0 (ref) 1.14 (0.97 –1.34) 1.22 (1.04 –1.44)a 1.21 (1.03 –1.42)a <0.05
Model 2 1.0 (ref) 1.06 (0.90 –1.25) 1.09 (0.92 –1.30) 0.99 (0.83 –1.18) NS
FBS ≥ 100 mg/dL Q1 Q2 Q3 Q4 P for trends
Insulin, μIU/mL (median) <4.7 (3.53) 4.7–6.5 (5.62) 6.5–9.4 (7.84) >9.4 (13.39)
Adenoma cases/non‐cases 360/509 340/499 372/493 412/424  
Univariate 1.0 (ref) 0.96 (0.79 –1.17) 1.07 (0.88 –1.29) 1.37 (1.14 –1.66)a <0.05
Model 1 1.0 (ref) 1.13 (0.91 –1.40) 1.25 (1.01 –1.54)a 1.70 (1.37 –2.10)a <0.05
Model 2 1.0 (ref) 1.08 (0.87 –1.34) 1.15 (0.93 –1.42) 1.47 (1.17 –1.87)a <0.05
a

< 0.05. Model 1: Adjusted for age, sex, current smoking, alcohol drinking, family history of colorectal cancer. Model 2: Further adjusted for body mass index. CI, confidence interval; FBS, fasting blood sugar; NS, not significant; OR, odds ratio; Q, quartile; ref, reference.